INVESCO Ltd (IVZ)
29.51
-0.58 (-1.93%)
NYSE · Last Trade: Oct 11th, 10:05 PM EDT
Pharmaceutical stocks have been one of the best places to invest over the past year. Choosing between these two funds is really a question about how you want to own what comes next.
Via The Motley Fool · October 11, 2026
One offers broad diversification at 0.08% cost, while the other targets concentrated biotech growth with higher volatility.
Via The Motley Fool · October 11, 2026
Global X's midstream fund delivered $2,531 on a $1,000 investment over five years, while Invesco's solar play returned just $565 despite higher fees.
Via The Motley Fool · October 11, 2026
PJP's one-year return beats RSPH's, but RSPH offers broader diversification across 61 healthcare holdings at a lower expense ratio.
Via The Motley Fool · October 11, 2026
The two earlier streaks like it both ended with a down year of over 30%. Is today's run built any differently?
Via The Motley Fool · October 10, 2026
History says that betting on the overall technology sector is a winning portfolio move.
Via The Motley Fool · October 10, 2026
KBWB delivered stronger 5-year returns and lower volatility, while IAT offers higher dividend income for yield-focused investors.
Via The Motley Fool · October 9, 2026
Stocks and bonds had an historically bad September. The good news is that there are alternatives if you want to reduce portfolio risk.
Via The Motley Fool · October 9, 2026
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch...
Via StockStory · October 8, 2026
A vulnerable stock market doesn't necessarily mean you should sell.
Via The Motley Fool · October 7, 2026
Vanguard FTSE Canada All Cap Index ETF (TSX:VCN) are a lower-cost way to diversify more quickly and efficient with that first $1,000.
Via The Motley Fool · October 7, 2026
IYK delivered higher five-year returns, while RSPS offers a higher dividend yield.
Via The Motley Fool · October 7, 2026
VanEck offers lower costs and double the dividend yield, while Invesco delivered stronger 1-year returns with more balanced holdings.
Via The Motley Fool · October 2, 2026
It's far from time to begin doomsday prepping.
Via The Motley Fool · October 2, 2026
These four ETFs target different areas of the market and work well together to mitigate portfolio risk.
Via The Motley Fool · October 2, 2026
Stock market downturns often present investors with incredible buying opportunities.
Via The Motley Fool · October 2, 2026
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the custody bank stocks, including Invesco (NYSE:IVZ) and its peers. Custody banks safe...
Via StockStory · October 1, 2026
KBWB's concentrated portfolio of 26 major banks delivered 14.7% returns over one year, while KRE's broader 167-holding approach yielded 12.5%.
Via The Motley Fool · October 1, 2026
The stock market is one of the best vehicles for building wealth.
Via The Motley Fool · September 30, 2026
Amid AI slowdown concerns, semiconductor ETFs like SOXX, DRAM, and SOXQ offer diversified exposure to chipmakers, each with distinct holdings, fees, and strong year-to-date returns.
Via MarketBeat · September 30, 2026
VOO and QQQ are among the world's most popular ETFs. Here's how to decide which is the best fit for your portfolio.
Via The Motley Fool · September 29, 2026
This potent exchange-traded fund has significantly outperformed the S&P 500 index.
Via The Motley Fool · September 29, 2026
The Nasdaq-100 index is full of high-priced tech stocks, which could make it a bit riskier to track these days.
Via The Motley Fool · September 29, 2026
As the Nasdaq-100 nears its all-time high, QQQ, XLK, SMH, QQQI, and SOXX offer distinct ways to gain tech and semiconductor exposure, from low-cost to income-focused options.
Via MarketBeat · September 28, 2026
This ETF focuses on the highest quality S&P 500 members.
Via The Motley Fool · September 28, 2026